Smith And Nephew Plc (SNN) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Smith and Nephew Plc  (NYSE: SNN)

Select the Financial Report: Select the Period:


Description of Smith And Nephew Plc's Business Segments


Smith & Nephew Plc is a global medical technology company that specializes in the design, manufacture, and marketing of a wide range of medical devices, and technologies aimed at improving the quality of life for patients and enhancing the effectiveness of healthcare providers. The companys operations are organized into several key segments, each offering distinct products and services tailored to specific medical needs.

Segments

1. Orthopaedics:
- This segment encompasses a variety of products focused on joint surgery and reconstruction. Smith & Nephews orthopaedic offerings include devices used in hip and knee arthroplasties. The company provides both total joint replacement solutions and partial replacement systems. Their advancements in minimally invasive techniques aim to reduce recovery time and improve patient outcomes.

2. Wound Management:
- Smith & Nephew has a comprehensive portfolio designed for the treatment of acute and chronic wounds. This includes advanced wound dressings, antimicrobial products, and negative pressure wound therapy systems. Their services in this segment are aimed at improving healing rates and managing complex wounds effectively.

3. Sports Medicine:
- Within the sports medicine segment, Smith & Nephew focuses on products related to arthroscopy and soft tissue repair. This includes various instruments and devices for ligament reconstruction, meniscal repair, and rotator cuff repair, emphasizing minimally invasive techniques that allow for faster recovery times and less postoperative discomfort.

4. Advanced Wound Care:
- Complementing their Wound Management offerings, this segment features advanced products designed to promote healing and tissue regeneration. This includes hydrocolloid and foam dressings, specialty meshes for burns and complex wounds, and other innovative technologies.

5. Trauma and Extremities:
- This segment focuses on devices used for trauma procedures such as fracture fixation and reconstruction in extremities. Smith & Nephew provides products that include plates, screws, and other hardware tailored for specific fractures and injuries, enhancing trauma surgical solutions.

6. Robotics and Digital Surgery:
- Recently, Smith & Nephew has made significant investments in robotic-assisted technologies and digital health solutions. These innovations aim to improve surgical precision and enhance patient outcomes while providing surgeons with advanced tools for performing complex procedures.

Products

1. Orthopaedic Implants:
- High-quality implants including total hip and knee systems, as well as advanced materials designed to enhance bone integration and reduce wear over time.

2. Wound Care Dressings:
- A range of innovative dressings designed to manage exudate, promote moist wound healing, and reduce the risk of infection. Products like the OpSite and Allevyn families are notable within this category.

3. Surgical Instruments and Implants:
- Specialized instruments for arthroscopic surgeries, including shavers, anchors, and other devices essential for performing precise procedures in the joint space.

4. Negative Pressure Wound Therapy:
- Devices like the PICO System, which utilize negative pressure to aid in wound healing by promoting blood flow and reducing swelling.

5. Fracture Fixation Devices:
- Comprehensive solutions for the treatment of fractures, including intramedullary nails, locking plates, and external fixators tailored for various clinical scenarios in orthopaedic trauma.

6. Robotic Systems:
- Robotic platforms designed to assist in surgical procedures, allowing for enhanced accuracy and consistency during operations.

Services

1. Surgeon Education and Training:
- Smith & Nephew provides educational programs and hands-on training for surgeons and medical staff, ensuring they are well-versed in the latest surgical techniques and the use of innovative products.

2. Clinical Support:
- The company offers dedicated clinical teams to support healthcare providers in implementing and optimizing their products within hospitals and clinics, ensuring effective patient management.

3. Rehabilitation Services:
- They extend their focus beyond the surgical procedure to include recovery, offering guidelines and resources to assist in the rehabilitation process post-surgery.

4. Supply Chain Solutions:
- Smith & Nephew ensures that hospitals and clinics receive timely and efficient delivery of products, often utilizing advanced logistics solutions to manage inventory and distribution.

In summary, Smith & Nephew Plc presents a diversified array of products and services across key segments in the medical technology industry. Their commitment to innovation and quality underscores their role as a leader in providing solutions for orthopaedics, wound management, sports medicine, trauma, and advanced surgical technologies.




Annual Report on Smith and Nephew Plc Divisions, Sales by Country

 
Established Markets   Established Markets Segment contribution to total sales 83.73 % of total Revenue
United States of America   United States of America Segment contribution to total sales 53.63 % of total Revenue
United Kingdom   United Kingdom Segment contribution to total sales 3.99 % of total Revenue
Emerging Markets   Emerging Markets Segment contribution to total sales 16.27 % of total Revenue
China   China Segment contribution to total sales 2.08 % of total Revenue
Advanced Wound Management   Advanced Wound Management Segment contribution to total sales 29.09 % of total Revenue
Advanced Wound Management Established Markets   Advanced Wound Management Established Markets Segment contribution to total sales 25.23 % of total Revenue
Advanced Wound Management Emerging Markets   Advanced Wound Management Emerging Markets Segment contribution to total sales 3.88 % of total Revenue
Orthopaedics Sports Medicine and Ear Nose and Throat   Orthopaedics Sports Medicine and Ear Nose and Throat Segment contribution to total sales 70.9 % of total Revenue
Orthopaedics Sports Medicine and Ear Nose and Throat Established Markets   Orthopaedics Sports Medicine and Ear Nose and Throat Established Markets Segment contribution to total sales 58.5 % of total Revenue
Orthopaedics Sports Medicine and Ear Nose and Throat Emerging Markets   Orthopaedics Sports Medicine and Ear Nose and Throat Emerging Markets Segment contribution to total sales 12.39 % of total Revenue
Orthopaedics   Orthopaedics Segment contribution to total sales 39.54 % of total Revenue
Orthopaedics Knee Implants   Orthopaedics Knee Implants Segment contribution to total sales 16.4 % of total Revenue
Orthopaedics Hip Implants   Orthopaedics Hip Implants Segment contribution to total sales 10.4 % of total Revenue
Orthopaedics Other Reconstruction   Orthopaedics Other Reconstruction Segment contribution to total sales 2.21 % of total Revenue
Orthopaedics Trauma Extremities   Orthopaedics Trauma Extremities Segment contribution to total sales 10.53 % of total Revenue
Sports Medicine ENT   Sports Medicine ENT Segment contribution to total sales 31.38 % of total Revenue
Sports Medicine ENT Sports Medicine Joint Repair   Sports Medicine ENT Sports Medicine Joint Repair Segment contribution to total sales 17.31 % of total Revenue
Sports Medicine ENT Arthroscopic Enabling Technologies   Sports Medicine ENT Arthroscopic Enabling Technologies Segment contribution to total sales 10.5 % of total Revenue
Sports Medicine ENT ENT Ear Nose and Throat   Sports Medicine ENT ENT Ear Nose and Throat Segment contribution to total sales 3.57 % of total Revenue
Advanced Wound Management Advanced Wound Care   Advanced Wound Management Advanced Wound Care Segment contribution to total sales 12.43 % of total Revenue
Advanced Wound Management Advanced Wound Bioactives   Advanced Wound Management Advanced Wound Bioactives Segment contribution to total sales 10.07 % of total Revenue
Advanced Wound Management Advanced Wound Devices   Advanced Wound Management Advanced Wound Devices Segment contribution to total sales 6.59 % of total Revenue


Twelve months ended 2025
SNN s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Established Markets 5,161.00 83.73 %
United States of America 3,306.00 53.63 %
United Kingdom 246.00 3.99 %
Emerging Markets 1,003.00 16.27 %
China 128.00 2.08 %
Advanced Wound Management 1,793.00 29.09 %
Advanced Wound Management Established Markets 1,555.00 25.23 %
Advanced Wound Management Emerging Markets 239.00 3.88 %
Orthopaedics Sports Medicine and Ear Nose and Throat 4,370.00 70.9 %
Orthopaedics Sports Medicine and Ear Nose and Throat Established Markets 3,606.00 58.5 %
Orthopaedics Sports Medicine and Ear Nose and Throat Emerging Markets 764.00 12.39 %
Orthopaedics 2,437.00 39.54 %
Orthopaedics Knee Implants 1,011.00 16.4 %
Orthopaedics Hip Implants 641.00 10.4 %
Orthopaedics Other Reconstruction 136.00 2.21 %
Orthopaedics Trauma Extremities 649.00 10.53 %
Sports Medicine ENT 1,934.00 31.38 %
Sports Medicine ENT Sports Medicine Joint Repair 1,067.00 17.31 %
Sports Medicine ENT Arthroscopic Enabling Technologies 647.00 10.5 %
Sports Medicine ENT ENT Ear Nose and Throat 220.00 3.57 %
Advanced Wound Management Advanced Wound Care 766.00 12.43 %
Advanced Wound Management Advanced Wound Bioactives 621.00 10.07 %
Advanced Wound Management Advanced Wound Devices 406.00 6.59 %
Total 6,164.00 100 %


Twelve months ended 2025
SNN s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total 625.00 10.14 %

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Established Markets 6.85 % -
United States of America 5.86 % -
United Kingdom 8.85 % -
Emerging Markets 2.35 % -
China -39.05 % -
Advanced Wound Management 6.66 % -
Advanced Wound Management Established Markets 6.22 % -
Advanced Wound Management Emerging Markets 10.14 % -
Orthopaedics Sports Medicine and Ear Nose and Throat 5.84 % -
Orthopaedics Sports Medicine and Ear Nose and Throat Established Markets 7.13 % -
Orthopaedics Sports Medicine and Ear Nose and Throat Emerging Markets 0.13 % -
Orthopaedics 5.73 % -
Orthopaedics Knee Implants 3.48 % -
Orthopaedics Hip Implants 3.55 % -
Orthopaedics Other Reconstruction 34.65 % -
Orthopaedics Trauma Extremities 6.74 % -
Sports Medicine ENT 6.03 % -
Sports Medicine ENT Sports Medicine Joint Repair 8.66 % -
Sports Medicine ENT Arthroscopic Enabling Technologies 2.37 % -
Sports Medicine ENT ENT Ear Nose and Throat 4.76 % -
Advanced Wound Management Advanced Wound Care 4.22 % -
Advanced Wound Management Advanced Wound Bioactives 6.88 % -
Advanced Wound Management Advanced Wound Devices 11.23 % -
Sports Medicine Joint Repair Sports Medicine ENT - -
Arthroscopic Enabling Technologies Sports Medicine ENT - -
ENT Ear Nose and Throat Sports Medicine ENT - -
Knee Implants Orthopaedics - -
Hip Implants Orthopaedics - -
Other Reconstruction Orthopaedics - -
Trauma Extremities Orthopaedics - -
Advanced Wound Care Advanced Wound Management - -
Advanced Wound Bioactives Advanced Wound Management - -
Advanced Wound Devices Advanced Wound Management - -
Orthopaedics Sports Medicine and ENT and Advanced Wound Management - -
Orthopaedics Sports Medicine and ENT and Advanced Wound Management Established Markets - -
Orthopaedics Sports Medicine and ENT and Advanced Wound Management Emerging Markets - -
Total 6.09 % 51.7 %



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.